![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Reprints |
Permissions |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
REVIEWS QUESTIONS AND CONTROVERSIES IN SURGERY IN 2010
Minerva Chirurgica 2010 December;65(6):635-54
Copyright © 2011 EDIZIONI MINERVA MEDICA
language: English
Endoluminal management of bronchogenic carcinoma in 2010: diagnosis, staging, and therapy
Horne Z. D., Landreneau R. J., Luketich J. D., Schuchert M. J. ✉
Division of Thoracic Surgery, Heart, Lung and Esophageal Surgery Institute, University of Pittsburgh Medical Center Pittsburgh, PA, USA
Endoluminal bronchogenic carcinoma, though a minority of lung cancer cases, presents a unique opportunity to utilize techniques for the diagnosis and therapy that are unavailable for more peripheral tumors. This review explores current techniques for the diagnosis, staging, and therapy of endoluminal central bronchogenic tumors and also introduces techniques currently under investigation as potential improvements or replacements for current techniques using recent literature. Additionally, the new staging criteria set forth in the 7th edition of the TMN staging system as a result of the American Joint Committee on Cancer (AJCC), International Union Against Cancer (IUCC), and the International Association for the Study of Lung Cancer (IASLC) are discussed with respect to endoluminal bronchogenic carcinoma.